Inventor · disambiguated record
Fangmin Xu
Also filed as: XU FANGMIN
14 granted patents·5 pending applications·132 citations·filing 2015–2024
92Inventor score
Top patents by PatentIndex Score
19 records- 0198US10981990B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2020·Granted Apr 20, 2021·11 cites·30 claims
- 0298US9605070B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 28, 2017·67 cites·85 claims
- 0395US11155620B2Method of detecting TIM-3 using antibody molecules to TIM-3NOVARTIS AG·Filed 2019·Granted Oct 26, 2021·6 cites·20 claims
- 0493US10654914B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2018·Granted May 19, 2020·5 cites·21 claims
- 0593US10472419B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 12, 2019·12 cites·57 claims
- 0693US9884913B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Feb 6, 2018·12 cites·30 claims
- 0791US11639378B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2021·Granted May 2, 2023·1 cites·19 claims
- 0889US10435460B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2017·Granted Oct 8, 2019·5 cites·26 claims
- 0989US2025051423A1Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1088US11161894B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2019·Granted Nov 2, 2021·2 cites·21 claims
- 1188US10450366B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2016·Granted Oct 22, 2019·5 cites·21 claims
- 1286US12077571B2Polyomavirus neutralizing antibodiesNOVARTIS AG·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 1384US9862760B2Polyomavirus neutralizing antibodiesABEND JOHANNA·Filed 2016·Granted Jan 9, 2018·6 cites·26 claims
- 1482US2025213684A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2024·Application pending·0 cites
- 1578US2022185883A1Method of detecting tim-3 using antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1670US2022133889A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1763US11802152B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2021·Granted Oct 31, 2023·0 cites·7 claims
- 1856US2018207273A1Combination therapies comprising antibody molecules to tim-3DRANOFF GLENN·Filed 2016·Application pending·0 cites
- 1949US11236159B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2016·Granted Feb 1, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Fangmin Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →